Amazon.com stock analysis: 19.6% revenue growth and a 242% earnings jump, but profit leans on non-operating gains and FCF is thin. Model: Hold.
@2026 – All Right Reserved.
Tag:
fundamental analysis
-
-
FeaturedSoftwareUS Stocks
Corpay Earns a Buy Signal on Margins and Cash Flow, With Leverage the Main Caveat
Corpay stock analysis: 80.5% gross margins and a 7.3% free cash flow yield earn a model Buy, but debt-to-equity of 2.75 and a near-high price are risks.
-
BiotechnologyUS Stocks
Faeth Therapeutics Trades Near Its Two-Year High While the Fundamentals Stay Pre-Revenue
Faeth Therapeutics stock analysis: a pre-revenue clinical biotech trading near its two-year high, with no debt, steep losses and a model rating of N/A.
-
BiotechnologyUS Stocks
Madrigal’s Revenue Is Up 71% as Rezdiffra Ramps – the Stock Is Already Near Its Highs
Madrigal Pharmaceuticals stock analysis: 71% revenue growth meets a rich 24x price-to-book near two-year highs. Model signal: Hold.
-
SoftwareUS Stocks
CoreWeave Is Burning $9 Billion a Year to Chase AI Demand – Can the Balance Sheet Keep Up?
CoreWeave stock analysis: 112% revenue growth collides with a -$9.1B free cash flow and 10x leverage. Model signal: Sell.
-
BiotechnologyUS Stocks
IDEAYA Biosciences: Trading Near a Two-Year High While the Model Flags a Sell
IDEAYA Biosciences, Inc. stock analysis: shares sit near a two-year high while a -36.4% gross margin and 25/100 quality score drive a Sell signal.
-
Insmed Incorporated stock analysis: revenue up 296.1% with a 90/100 growth score, offset by a -76.9% net margin and a Hold signal from our model.